Clinical Trials Directory

Trials / Completed

CompletedNCT00826228

Effect of Parathyroid Hormone (PTH) and Weight-Bearing on Bone in Spinal Cord Injury (SCI)

Effect of PTH Combined With Weight-Bearing on Bone Density and Bone Architecture in People With Spinal Cord Injury

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
12 (actual)
Sponsor
Thomas J. Schnitzer · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

Individuals with spinal cord injury sustain significant loss of bone mass in their lower extremities (20-40% or more). This study evaluates the ability of PTH and weight-bearing, two interventions that build bone, to increase bone mass in this population.

Detailed description

This pilot project aims to evaluate PTH with weight-bearing in a group of individuals with chronic SCI and loss of bone mass in their lower extremities. A convenience sample of 12 people with SCI will be enrolled into a 6 month study assessing the effects of a weight-bearing regime plus daily PTH (Forteo 20ug sc) on BMD and bone markers. Subjects will be evaluated at 3 and 6 months after initiating treatment with measurement of bone density as well as bone markers of formation and resorption. An optional extension to 12 months will be offered to all subjects.

Conditions

Interventions

TypeNameDescription
DRUGteriparatideteriparatide 20ug daily sc for 6 months
OTHERweight-bearingdevice assisted walking

Timeline

Start date
2009-06-01
Primary completion
2012-03-01
Completion
2012-12-01
First posted
2009-01-22
Last updated
2013-07-11
Results posted
2013-07-11

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00826228. Inclusion in this directory is not an endorsement.